|
A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. Clinical research trials and A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.. A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. clinical trial. Subjects frequently get the best healthcare possible for their A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation. condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.  A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.
A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.
For Condition: Hematologic Neoplasms,Sepsis,Infection,Hematopoietic Stem Cell Transplantation
Status: Terminated
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study is to determine how Xigris® will affect leukemia, lymphoma and myeloma patients who develop severe sepsis within 60 days of starting chemotherapy in preparation for bone marrow transplant (BMT). This study will: ·Evaluate the safety of Xigris® by assessing the risk of serious bleeding events, including bleeding within the brain and serious bleeding leading to death. ·Evaluate whether Xigris® can reduce death in BMT patients who develop severe sepsis.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: 1. Participants must have cancer of the blood (Leukemia, Lymphoma or Myeloma). 2. Participants must have had treatment in prepartation for a bone marrow transplant within the past 60 days. 3.Participants must have proven or suspected infection. 4.Participants must be on a breathing maching or require medication to maintain their blood pressure. Exclusion Criteria: 1.Participants must not have increased bleeding risk due to medical conditions or medications. 2.Participants must not be pregnant or breastfeeding. 3.Participants must not have serious liver disease. 4.Participants must not have been involved in a study of an investigational drug used to treat any disease other than cancer within the past 30 days.
Total Enrollment:
Location and Contact Information:
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician."
Iowa City, Iowa,
United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician."
Winston Salem, North Carolina,
United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician."
Durham, North Carolina,
United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician."
Denver, Colorado,
United States
"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician."
Manhassaet, New York,
United States
Additional Information:
Study ID Numbers: 6416;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067730
Other Sepsis Studies:
1. A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.
2. Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
3. Posaconazole to Treat Invasive Fungal Infections
4. Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
5. Infection and Cardiovascular Disease
Related Studies:
Other Sepsis Clinical Trials
Other Colorado Clinical Trials
Other Denver Clinical Trials
A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.
|
|
|
|
|
|
|
|
